CAMP
NASDAQ HealthcareCAMP4 Therapeutics Corporation - Common Stock
Biotechnology
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
�� 市场数据
| 价格 | $5.00 |
|---|---|
| 成交量 | 560,121 |
| 市值 | 313.77M |
| RSI（14日） | 70.7 超买 |
| 200日均线 | $4.47 |
| 50日均线 | $4.08 |
| 52周最高 | $7.75 |
| 52周最低 | $1.41 |
| Forward P/E | -6.29 |
| Price / Book | -384.62 |
🎯 投资策略评分
CAMP 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (82/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 🚀 Moon Shot (4/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 CAMP in your text
粘贴任何文章、记录或帖子 — 工具将提取 CAMP 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-08-17.